IP Library Granted Patent US 10,726,110
Granted Patent B2
US 10,726,110 · App. 15/907,835 · Granted Jul 28, 2020

Watermarking for data security in bioinformatic sequence analysis

Inventors: Kaushik Ghose (Malden, MA); Deniz Kural (Somerville, MA)
Assignee: Seven Bridges Genomics, Inc.
G06F21/16G06F16/9024G16B5/00G16B30/00G16B50/00G16B50/40G16B30/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,726,110
App. No.
15/907,835
Granted
Jul 28, 2020
Kind
B2
Abstract

Embodiments of the invention protect information stored in graph-based sequence references by “watermarking” the graph with uniquely identifiable information. The watermark identifies the graph or version thereof in a detectable but nonintrusive manner. In one embodiment, insertions and/or deletions are introduced into regions of the graph.

Claims (19)

1. A system for modifying a deoxyribonucleic acid (DNA) sequence corresponding to a genome or portion thereof and represented as a reference graph, the system comprising:

a memory partition for storing the sequence; and

a watermarking module for modifying the sequence by introducing a watermarking artifact therein, the watermarking artifact comprising at least one of (a) a plurality of variants not found in natural genomic DNA, (b) a variant introduced in a repeat sequence other than the first of a plurality of repeat sequences in a repetitive region, (c) at least one sequence no longer than 30 bp not found in natural genomic DNA, or (d) metadata associated with variants in the reference graph, wherein the graph includes multiple paths at least one of which corresponds to a natural DNA sequence and another of which includes the watermarking artifact.

2. The system of claim 1 , wherein the watermarking artifact is introduced in a region within 100 bp, 250 bp, or 500 bp of centromere DNA.

3. The system of claim 1 , wherein the at least one variant is in a k-mer with k ranging from 15-30 bp.

4. The system of claim 1 , wherein the metadata includes variant allele frequency information.

5. The system of claim 1 , wherein a watermarking artifact comprises a frameshift in an essential gene.

6. The system of claim 1 , wherein a watermarking artifact encodes an alternative protein sequence.

7. The system of claim 6 , wherein the alternative protein sequence spells a word in a language.

8. The system of claim 1 , wherein a variant introduced in a repeat sequence comprises a variant introduced in the middle of a repeat sequence.

9. The system of claim 1 , wherein a variant not found in natural genomic DNA comprises a private variant found only in a single individual.

10. The system of claim 9 , wherein the private variant is identified from a trio experiment.

11. A method of watermarking a deoxyribonucleic acid (DNA) sequence corresponding to a genome or portion thereof and represented as a reference graph and stored as a data structure in a computer memory, the method comprising modifying the memory contents corresponding to the sequence by introducing a watermarking artifact therein, the watermarking artifact comprising at least one of (a) a plurality of variants not found in natural genomic DNA, (b) a variant introduced in a repeat sequence other than the first of a plurality of repeat sequences in a repetitive region, (c) at least one sequence no longer than 30 bp not found in natural genomic DNA, or (d) metadata associated with variants in the reference graph, wherein the graph includes multiple paths at least one of which corresponds to a natural DNA sequence and another of which includes the watermarking artifact.

12. The method of claim 11 , wherein the watermarking artifact is introduced in a region within 100 bp, 250 bp, or 500 bp of centromere DNA.

13. The method of claim 11 , wherein the metadata includes variant allele frequency information.

14. The method of claim 11 , wherein a watermarking artifact comprises a frameshift in an essential gene.

15. The method of claim 11 , wherein a watermarking artifact encodes an alternative protein sequence.

16. The method of claim 11 , wherein a variant introduced in a repeat sequence comprises a variant introduced in the middle of a repeat sequence.

17. The method of claim 11 , wherein a variant not found in natural genomic DNA comprises a private variant found only in a single individual.

Assignments (5)
SECURITY INTEREST Recorded Aug 4, 2022
From: PIERIANDX, INC.; SEVEN BRIDGES GENOMICS INC.
To: ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
Reel/Frame 061084/0786 →
RELEASE OF SECURITY INTEREST Recorded Aug 2, 2022
From: IMPERIAL FINANCIAL SERVICES B.V.
To: SEVEN BRIDGES GENOMICS INC.
Reel/Frame 061055/0078 →
RELEASE OF SECURITY INTEREST Recorded May 24, 2022
From: IMPERIAL FINANCIAL SERVICES B.V.
To: SEVEN BRIDGES GENOMICS INC.
Reel/Frame 060173/0792 →
SECURITY INTEREST Recorded May 24, 2022
From: SEVEN BRIDGES GENOMICS INC.
To: IMPERIAL FINANCIAL SERVICES B.V.
Reel/Frame 060173/0803 →
SECURITY INTEREST Recorded Mar 30, 2022
From: SEVEN BRIDGES GENOMICS INC.
To: IMPERIAL FINANCIAL SERVICES B.V.
Reel/Frame 059554/0165 →
Continuity (2)
Provisional Application 62465454 · Mar 1, 2017
Related Publication 20180253536A1 · Sep 6, 2018